STRS Ohio
AKBA icon

STRS Ohio’s Akebia Therapeutics AKBA Stock Holding History

STRS Ohio’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$97.8K Buy
+106,300
New +$114K ﹤0.01% 1888
2022
Q2 		– Sell
-285,500
Closed -$204K – 2037
2022
Q1 		$204K Hold
285,500
– – ﹤0.01% 1705
2021
Q4 		$645K Hold
285,500
– – ﹤0.01% 1392
2021
Q3 		$822K Buy
285,500
+55,700
+24% +$159K ﹤0.01% 1235
2021
Q2 		$870K Buy
229,800
+11,400
+5% +$38.4K ﹤0.01% 1253
2021
Q1 		$739K Hold
218,400
– – ﹤0.01% 1385
2020
Q4 		$611K Hold
218,400
– – ﹤0.01% 1369
2020
Q3 		$548K Buy
218,400
+148,500
+212% +$1.3M ﹤0.01% 1277
2020
Q2 		$949K Buy
69,900
+62,900
+899% +$651K ﹤0.01% 912
2020
Q1 		$53K Buy
+7,000
New +$54.5K ﹤0.01% 1775
2019
Q4 		– Sell
-47,800
Closed -$187K – 2054
2019
Q3 		$187K Hold
47,800
– – ﹤0.01% 1663
2019
Q2 		$231K Buy
47,800
+2,700
+6% +$15.4K ﹤0.01% 1666
2019
Q1 		$369K Buy
45,100
+2,300
+5% +$15.8K ﹤0.01% 1456
2018
Q4 		$236K Buy
42,800
+17,700
+71% +$139K ﹤0.01% 1599
2018
Q3 		$221K Sell
25,100
-1,500
-6% -$13.4K ﹤0.01% 1695
2018
Q2 		$265K Sell
26,600
-25,100
-49% -$251K ﹤0.01% 1663
2018
Q1 		$492K Hold
51,700
– – ﹤0.01% 1324
2017
Q4 		$768K Buy
51,700
+5,700
+12% +$94.5K ﹤0.01% 1034
2017
Q3 		$904K Hold
46,000
– – ﹤0.01% 923
2017
Q2 		$661K Buy
+46,000
New +$583K ﹤0.01% 1170
2015
Q1 		– Sell
-2,700
Closed -$28.7K – 1804
2014
Q4 		$31K Hold
2,700
– – ﹤0.01% 1658
2014
Q3 		$60K Buy
+2,700
New +$62K ﹤0.01% 1625

Other funds holding AKBA

Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return
Choreo LLC
Choreo LLC Rockford, Illinois $9.7B AUM 18.43% 1-Year Est. Return
CWA Asset Management Group
CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return
PFG Private Wealth Management
PFG Private Wealth Management Lutz, Florida $236M AUM 9.86% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Traynor Capital Management
Traynor Capital Management Malvern, Pennsylvania $2.17B AUM 49.16% 1-Year Est. Return
Unified Investment Management
Unified Investment Management Atlanta, Georgia $114M AUM 22.27% 1-Year Est. Return

STRS Ohio's AKBA Position: Q3 2026 in Review

STRS Ohio opened a new position in Akebia Therapeutics (AKBA) in Q3 2026: 106,300 shares worth $97.8K. The stake represents ﹤0.01% of the portfolio and ranks #1888 among its holdings. This is a return to the name: STRS Ohio previously reported a position in AKBA as recently as Q1 2022.

STRS Ohio first reported a position in AKBA in Q3 2014 and has held it in 22 quarters since. The position peaked at $949K in Q2 2020. 35 funds tracked by Wall St. Rank hold AKBA as of Q3 2026.

  • STRS Ohio held 106,300 shares of Akebia Therapeutics worth $97.8K as of Q3 2026.
  • Akebia Therapeutics was a new STRS Ohio position in Q3 2026.
  • Akebia Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q3 2026, its #1888 holding.
  • STRS Ohio first reported a position in Akebia Therapeutics in Q3 2014 and has held it in 22 quarters since.
  • STRS Ohio's Akebia Therapeutics position peaked at $949K in Q2 2020.
  • 35 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q3 2026.

Based on STRS Ohio's 13F filing for Q3 2026, filed 30 Oct 2026.